Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Itron announced that it’s working together with Water Corporation to modernize the utility’s water distribution system.
-
NORTH BRUNSWICK, N.J., Sept. 12, 2024 (GLOBE NEWSWIRE) -- BioAegis Therapeutics, a pioneering biotech company at the forefront of innovative therapies for inflammatory diseases, announces that its...
-
LIBERTY LAKE, Wash., June 12, 2024 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), che propone modalità innovative per le Aziende per la distribuzione dell’energia (Utilitiies) e le Municipalità per...
-
Integra S.R.L. to help utilities and cities in Italy enhance their grid infrastructure with Itron’s solutions.
-
BioAegis announces global Phase 2 study of its inflammation regulator protein, gelsolin, for the treatment of Acute Respiratory Distress Syndrome (ARDS).
-
Partnership supports execution of a large phase 2 global study to evaluate efficacy and safety of recombinant human plasma gelsolin (rhu-pGSN) for moderate-to-severe ARDS. NORTH BRUNSWICK, N.J., Oct....
-
Pune, India, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The adoption of AMMR is increasing owing to the rise in automation in the warehouse and manufacturing industries. Further, the rise in demand for chips...
-
YONKERS, N.Y., Aug. 28, 2023 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs),...
-
Total revenue for the first half of 2023 was approximately $1.65 million, an increase of approximately 15% compared to approximately $1.44 million in the first half of 2022Signed FIND R&D...
-
ROCKVILLE, Md., Aug. 03, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) (“OpGen” or “the Company”) announced today that the Company will provide a business update and report its second quarter...